Related Experiment Video
Updated: May 4, 2026

Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
Eosinophilic myositis: an updated review
A Selva-O'Callaghan1, E Trallero-Araguás1, J M Grau2
1Internal Medicine Service, Hospital Vall d'Hebron, Universitat Autonoma de Barcelona, Barcelona, Spain.
Eosinophilia-associated myopathies are diverse muscle disorders. Diagnosis relies on muscle biopsy, identifying eosinophils or eosinophil major basic protein, guiding treatment for these conditions.
Area of Science:
- Neurology
- Immunology
- Pathology
Background:
- Eosinophilia-associated myopathies encompass heterogeneous conditions.
- Peripheral and/or muscle eosinophilia characterizes these disorders.
- Subtypes include focal eosinophilic myositis, eosinophilic polymyositis, and eosinophilic perimyositis.
Purpose of the Study:
- To review the clinical and pathological heterogeneity of eosinophilia-associated myopathies.
- To highlight diagnostic approaches and therapeutic strategies.
- To discuss the diverse etiologies and management of these conditions.
Main Methods:
- Review of literature on eosinophilia-associated myopathies.
- Analysis of diagnostic criteria, including muscle biopsy findings.
- Examination of treatment modalities and etiological factors.
Main Results:
- Muscle biopsy is crucial for diagnosis, often detecting eosinophil major basic protein.
- Eosinophilic polymyositis can link to muscular dystrophy or hypereosinophilic syndrome.
- Etiologies include parasitic infections, autoimmune disorders, malignancies, drugs, and idiopathic cases.
Conclusions:
- Eosinophilia-associated myopathies require careful diagnosis and management.
- Treatment varies based on etiology, with glucocorticoids for idiopathic forms.
- Targeted therapies like imatinib and mepolizumab show promise in specific cases, particularly within hypereosinophilic syndromes.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myocarditis III: Medical Management
Myasthenia Gravis ll: Pathophysiology
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis IV: Nursing Management

